Alexandra Kropotova
Net worth: 155 866 $ as of 31/05/2026
Net worth: 155 866 $ as of 31/05/2026
Alexandra Kropotova is currently an Independent Director at iBio, Inc. since 2020 and Chief Medical Officer & Executive Vice President at SAB Biotherapeutics, Inc. since 2022.
Formerly, Dr. Kropotova worked at Pfizer Inc. from 2002 to 2007 as Director & Head-Global Clinical Respiratory, at Sanofi from 2007 to 2016 as Vice President-Strategy & Head-Strategic Planning, and at Teva Pharmaceuticals, Inc. from 2016 to 2022 as VP-Global Specialty Research & Development.
Education includes an MBA from Ohio University Graduate College and a doctorate from Pacific State Medical University.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 24/03/2026 | 43,296 ( 0.06% ) | 155 866 $ | 31/05/2026 | |
IBIO, INC. -.--% | 20/11/2025 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Companies | Position | Start |
|---|---|---|
| IBIO, INC. | Director/Board Member | 14/10/2020 |
| SAB BIOTHERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 06/06/2022 |
| Companies | Position | End |
|---|---|---|
Teva Pharmaceuticals, Inc.
Teva Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Corporate Officer/Principal | 01/06/2022 |
| SANOFI | Corporate Officer/Principal | 01/01/2016 |
| PFIZER INC. | Director/Board Member | 01/01/2007 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 6 |
|---|---|
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Sanofi
Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
iBio, Inc.
iBio, Inc. Pharmaceuticals: OtherHealth Technology Engages in the development and commercialization of vaccines and therapeutic proteins | Health Technology |
Ohio University Graduate College
Ohio University Graduate College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SAB Biotherapeutics, Inc.
SAB Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in advancing a new class of immunotherapies | Health Technology |
Teva Pharmaceuticals, Inc.
Teva Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
Select your edition
All financial news and data tailored to specific country editions